Management confirmed the acceleration of the CBeyond trial timeline with topline data expected ... and manufacturing costs for nimacimab trials. General and administrative expenses rose to $4 ...

enabling collaboration with a broader national oncology and mental health network to accelerate the Phase II clinical trial timeline. Southern Star Research's scale and capabilities will support ...